Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmala Biotech Holdings Inc
C.MDMA
Alternate Symbol(s):
MDXXF
Healthcare
Biotechnology
PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines...
: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:MDMA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(141)
•••
Chefboy69
X
View Profile
View Bullboard History
Comment by
Chefboy69
on Dec 20, 2024 6:19pm
RE:Y/E Financials
It's a pharmaceutical company bro they're not going to be making lots of money right now the money is in the Partnerships that they have and very soon Nick is going to be doing a partnership
...more
(185)
•••
inviolablspirit
X
View Profile
View Bullboard History
Post by
inviolablspirit
on Dec 20, 2024 6:03pm
Y/E Financials
Just as predicted. The Y/E financials showed a modest year-over-year gain, which continues to show positive steps in the right direction and the EPS remained at (0.01) which is far, far better
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 20, 2024 4:55pm
New Press Release - PharmAla Issues Audited Financial Statements, Completes Continuance to Ontario, and Closes Private Placement
TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to...
read article.
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Dec 19, 2024 6:23am
Buzz on the Bullboards: Three engaging TSX stocks with a holiday flavour
The TSX has experienced a rocky week, marked by five consecutive sessions of declines, but several stocks offer compelling opportunities.
read article.
(141)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Dec 17, 2024 2:12pm
US market is starting to roll over.
Donald Trump's tariffs, and a 2-year bull market combined with an extremely fragile end of bull market. Now Animal Spirits Trump trade in full effect on the 6th week. I believe markets are going
...more
(141)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Dec 15, 2024 9:24am
Macro factors
Unfortunately there are bigger things going on in the market then the current news stream here. I'm very happy that Nick is all cashed up. I don't care who got in on the pp it doesn't
...more
(185)
•••
inviolablspirit
X
View Profile
View Bullboard History
Post by
inviolablspirit
on Dec 14, 2024 1:23pm
Investor
I see on CEO they have started throwing out the wild guesses as to who the "strategic high-net-worth investor" is. Who cares? Why hype up something like the identity of this
...more
(185)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Dec 13, 2024 11:26am
RE:RE:Private Placement
...and by the way I definitely grabbed more shares. I did mention in a previous post that if this gift came around I wasn't going to miss out in the possibility of adding more shares.
...more
(185)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Dec 13, 2024 10:58am
RE:Private Placement
I'm going to take a wild guess and say that a "single high-net-worth stratigic investor" doesn't like to lose money on their investment and so chooses their investments wisely.
...more
(185)
•••
inviolablspirit
X
View Profile
View Bullboard History
Post by
inviolablspirit
on Dec 13, 2024 10:13am
Private Placement
I knew something was up when I saw instinet show up, as they are brought in to execute trades for groups like hedge funds, mutual funds, insurance companies and pension funds. I'm going to
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 13, 2024 9:25am
New Press Release - PharmAla Announces Private Placement
TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to...
read article.
(185)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Dec 12, 2024 3:55pm
RE:RE:RE:RE:Chart
I noticed a couple of weeks ago as did another guy on CEO just recently mentioned it, that the outstanding shares in the company has decreased according to stockhouse and according to the platform
...more
(185)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Dec 12, 2024 3:39pm
RE:RE:RE:Chart
On the technical side, the RSI is now down to where it was when Pharmala was at 8.5 cents. This gives the stock plenty of upside. Money flow is also at the same level too. Although I
...more
(185)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Dec 12, 2024 3:25pm
RE:RE:Chart
Instinet looks to be the culprit as they only recently showed up. They execute trade for assest managment groups. I would think they have been using anonymous on the dumps to put the
...more
(185)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Dec 12, 2024 3:17pm
RE:Chart
I noticed the last few trading sessions the volume has picked up on the US exchanges. The push down looks to be coming from there.
(185)
•••
inviolablspirit
X
View Profile
View Bullboard History
Post by
inviolablspirit
on Dec 05, 2024 5:15pm
Chart
The chart continues to look good and is ready for another move up on a good news release. A solid base is being formed. I like the "W" formation running along this newly
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing